Modeling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance.

被引：0
|
作者：
Das Thakur, Meghna [1 ]
Fisher, Rosalie [2 ]
Salangsang, Fernando [1 ]
Landman, Allison [3 ]
Sellers, William [4 ]
Pryer, Nancy [1 ]
Levesque, Mitchell Paul [5 ]
Dummer, Reinhard [5 ]
Gore, Martin [2 ]
Larkin, James [2 ]
McMahon, Martin [3 ]
Stuart, Darrin [1 ]
机构：
[1] Novartis, Emeryville, CA USA
[2] Royal Marsden Hosp, London SW3 6JJ, England
[3] UCSF, San Francisco, CA USA
[4] Novartis, Cambridge, MA USA
[5] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-LB-144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB144
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Mechanism of Drug Sensitivity and Resistance in Melanoma
    La Porta, Caterina A. M.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (03) : 391 - 397
  • [42] Drug resistance in melanoma: New perspectives
    La Porta, Caterina A. M.
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (04) : 387 - 391
  • [43] Drug-resistance in human melanoma
    Helmbach, H
    Rossmann, E
    Kern, MA
    Schadendorf, D
    INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (05) : 617 - 622
  • [44] Melanoma cells with acquired resistance to vemurafenib have decreased autophagic flux and display enhanced ability to transfer resistance
    Perez, Celia N.
    Falcon, Cristian R.
    Mons, Johinna Delgado
    Orlandi, Federico Cuello
    Sangiacomo, Mercedes
    Fernandez-Munoz, Juan M.
    Guerrero, Martin
    Benito, Paula G.
    Colombo, Maria I.
    Zoppino, Felipe C. M.
    Alvarez, Sergio E.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2023, 1869 (07):
  • [45] The Role of eIF4E in Response and Acquired Resistance to Vemurafenib in Melanoma
    Zhan, Yao
    Dahabieh, Michael S.
    Rajakumar, Arjuna
    Dobocan, Monica C.
    M'Boutchou, Marie-Noel
    Goncalves, Christophe
    Shiru, Lucy L.
    Pettersson, Filippa
    Topisirovic, Ivan
    van Kempen, Leon
    del Rincon, Sonia V.
    Miller, Wilson H., Jr.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (05) : 1368 - 1376
  • [46] Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals
    Tabolacci, Claudio
    Cordella, Martina
    Mariotti, Sabrina
    Rossi, Stefania
    Senatore, Cinzia
    Lintas, Carla
    Levati, Lauretta
    D'Arcangelo, Daniela
    Facchiano, Antonio
    D'Atri, Stefania
    Nisini, Roberto
    Facchiano, Francesco
    BIOMEDICINES, 2021, 9 (01) : 1 - 19
  • [47] Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
    Atzori, Maria Grazia
    Ceci, Claudia
    Ruffini, Federica
    Trapani, Mauro
    Barbaccia, Maria Luisa
    Tentori, Lucio
    D'Atri, Stefania
    Lacal, Pedro Miguel
    Graziani, Grazia
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (01) : 465 - 475
  • [48] EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
    Miao, Benchun
    Ji, Zhenyu
    Tan, Li
    Taylor, Michael
    Zhang, Jianming
    Choi, Hwan Geun
    Frederick, Dennie T.
    Kumar, Raj
    Wargo, Jennifer A.
    Flaherty, Keith T.
    Gray, Nathanael S.
    Tsao, Hensin
    CANCER DISCOVERY, 2015, 5 (03) : 274 - 287
  • [49] Suppression of exosomal hsa_circ_0001005 eliminates the Vemurafenib resistance of melanoma
    Xicheng Wang
    Qiong Cheng
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5921 - 5936
  • [50] Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy
    Er, Asiye Busra Boz
    Sheldrake, Helen M.
    Sutherland, Mark
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
12345